Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CV 3317

Known as: CV-3317 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
BACKGROUND Angiotensin converting enzyme (ACE) inhibitors and Angiotensin II (AII) receptor blockers have previously been shown… Expand
Is this relevant?
1990
1990
The effect of the newly developed angiotensin-converting enzyme (ACE) inhibitor, delapril hydrochrolide (CV-3317), on the release… Expand
Is this relevant?
1989
1989
Delapril est administre a dose unique ou a doses repetees et on teste son action antihypertensive et ses effets sur les systemes… Expand
Is this relevant?
1988
1988
Pharmacokinetic properties of a new angiotensin-converting enzyme inhibitor, delapril (CV-3317), which converts to two active… Expand
Is this relevant?
1986
1986
N-[N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-N-(indan-2- yl)glycine hydrochloride (CV-3317) and its de-esterified… Expand
Is this relevant?
1986
1986
The antihypertensive action of N-[N-[(S)-1-ethoxycarbonyl-3-phenyl-propyl]-L-alanyl]-N-(indan-2-yl) glycine hydrochloride (CV… Expand
Is this relevant?
1986
1986
A new angiotensin converting enzyme (ACE) inhibitor, N-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-N-(indan-2-yl)glycine… Expand
Is this relevant?